NarcX Reassigns Executive Titles to Two of Its Pre-existing Executives: David A. Schiller is now (CEO) and Jordan Erskine is now (Principal)

    VINEYARD, UT, June 16, 2022 /24-7PressRelease/ -- David A. Schiller will change his title from Chief Compliance Officer to Chief Executive Officer while Jordan Erskine will change his title from Chief Executive Officer to Co-Founder & Principal.

"David fully embodies the ideals of NarcX," said Jordan Erskine, Principle and Co-Founder of NarcX. "There isn't anyone else I'd rather have in the driver's seat as CEO of our innovative company."

David A. Schiller brings over 30 years of experience with the United States Drug Enforcement Administration (DEA) to his new role at NarcX. In 2015, Schiller was selected to be the Vice Chair of DEA's Diversion Field Advisory Committee (DFAC), ultimately responsible for coordinating all diversion related matters for each of the DEA's 21 Field Divisions in the United States. Retiring from the DEA in 2017, he ended his distinguished career by finalizing the largest administrative and civil settlement against a DEA Registrant in history—the McKesson Corporation.

Jordan Erskine is a highly motivated entrepreneurial individual who has co-founded many successful businesses. He has over 20 years in the contract manufacturing and development industry where he is also a Co-Founder & Principal for the award-winning contract manufacturer Dynamic Blending. Jordan is passionate about helping to solve or mitigate the opioid epidemic. He, and the rest of the dedicated NarcX® team, is excited to bring the only on-site medication disposal method to the market.

"I am thrilled with the direction of NarcX," said Erskine. "We are truly in the midst of an exciting time in our company's history and can't wait to see where the future takes us."

"Jordan has been a great leader to all of us here at NarcX" said Schiller. "I look forward to continuing work with him as NarcX paves the way toward a safer, substance-free future."

NarcX is the leader in on-site medication disposal. Its patent-pending and environmentally safe product, NarcX, is the only liquid solution and on-site disposal option that is compliant with DEA policy and the Code of Federal Regulations. The proprietary blend of ingredients in NarcX immediately dissolves tablets, capsules and liquids, fully neutralizing compounds in under two hours as validated by an independent DEA-registered laboratory. Headquartered in Vineyard, Utah.

NarcX was founded with a mission to combat the diversion of narcotics, amphetamines, opiates and other frequently-abused controlled substances and to provide a convenient and affordable disposal option for unused, unwanted or expired medications. Through education and outreach, NarcX supports organizations in becoming compliant for medication disposal and destruction.

Related Link:
https://narcx.com

# # #